EMA accepts Isotechnika-Lux filing for eye drug
March 2, 2010 by leonardzehr · Leave a Comment
The European Medicines Agency has accepted a marketing application filed by Isotechnika Pharma’s (TSX:ISA) partner, Lux Biosciences, for voclosporin to treat non-infectious uveitis involving the posterior segment of the eye, the fourth leading cause of legal blindness in the industrialized world. “With the EMA acceptance of the dossier we now expect the review process to [...]
Listen to BioTuesdays 
